Martingale Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.35M	Buy	4,485 +1,099	+32%	+$525K	0.06%	308
2025 Q4	$1.97M	Sell	3,386 -1,129	-25%	-$577K	0.05%	320
2025 Q3	$2.07M	Sell	4,515 -930	-17%	-$347K	0.05%	306
2025 Q2	$1.65M	Sell	5,445 -99	-2%	-$29.5K	0.04%	341
2025 Q1	$1.84M	Sell	5,544 -370	-6%	-$122K	0.05%	317
2024 Q4	$1.82M	Buy	5,914 +150	+3%	+$42.2K	0.04%	332
2024 Q3	$1.22M	Buy	+5,764	New	+$1.47M	0.03%	416
2024 Q2	–	Sell	-6,163	Closed	-$1.65M	–	826
2024 Q1	$1.65M	Sell	6,163 -481	-7%	-$113K	0.03%	346
2023 Q4	$1.54M	Buy	6,644 +661	+11%	+$116K	0.03%	348
2023 Q3	$874K	Buy	5,983 +1,751	+41%	+$330K	0.02%	474
2023 Q2	$978K	Buy	4,232 +100	+2%	+$27.1K	0.02%	454
2023 Q1	$1M	Buy	+4,132	New	+$1.13M	0.02%	442
2021 Q4	–	Sell	-5,404	Closed	-$432K	–	862
2021 Q3	$432K	Buy	5,404 +2,801	+108%	+$242K	0.01%	693
2021 Q2	$254K	Buy	+2,603	New	+$308K	﹤0.01%	752